Antitrust regulators shouldn’t clear Novo Holdings’ planned acquisition of Catalent, Roche CEO Thomas Schinecker said Wednesday, adding to the pressure that industry competitors appear to …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
This week, I address pushback I received on my Novartis-MorphoSys column. But first, a preview of the expected readout from Gritstone Bio’s neoantigen cancer vaccine
Researchers discussed the role of artificial intelligence (AI) in preventing outbreaks of infectious diseases and future pandemics.
With advances in neuroscience and the development of new technologies, new ethical considerations have emerged.